Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis.
J Bone Oncol
; 25: 100319, 2020 Dec.
Article
em En
| MEDLINE
| ID: mdl-33088699
AJCC, American Joint Cancer Committee; ASCO, American Society of Clinical Oncology; Amputation; CATS, Computed Assisted Tumor Surgery; CCG, Children's Cancer Group; CI, Confidence Interval; COSS, Cooperative Osteosarcoma Study Group; CT, Computed Tomography; DFS, Disease Free Survival; FNA, Fine Needle Aspiration; LSS, Limb Salvage Surgery; Limb-salvage surgery; MAP, MTX, Adriamycin, Cisplatin; MRI, Magnetic Resonance Imaging; MSKCC, Memorial Sloan Kattering Cancer Center; MSTS, Musculoskeletal Tumor Society; NCCN, National Comprehensive Cancer Network; NOS, NewcastleOttawa scale; NPCR, National Program of Cancer Registries; Neoadjuvant chemotherapy; OR, Odds Ratio; OS, Overall Survival; Osteosarcoma; PET, Positron Emission Tomography; POG, Pediatric Oncology Group; RCT, Randomized Controlled Trials; Rev-Man, Review Manager; SEER, Surveillance, Epidemiology, and End Results; SIOP, International Society of Paediatric Oncology; Tc-MDP, Methylene diphosphonate with technetium-99m; VICC, Vanderbilt-Ingram Cancer Center
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Systematic_reviews
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article